In addition to drawing faculty from a variety of departments and schools around the university, NEIDL investigators collaborate widely with faculty from other research centers.
These collaborations promote innovation in emerging infectious diseases research within NEIDL.
In the News
-
A New Type of RNA Could Revolutionize Vaccines and Cancer Treatments
An accidental discovery turned into an unexpected success, when a team of interdisciplinary BU researchers created a new and improved COVID vaccine.
-
Modified Self-Amplifying RNA Provides Opportunities For New Vaccines And Treatments
A paper published on July 8, 2024 in the journal Nature Biotechnology presents promising data that offers a foundation for developing future vaccines and treatments.
-
After 30 years of decline, tuberculosis is rising in the U.S. again. How did we get here?
After declining for three decades, tuberculosis (TB) rates in the U.S. have been increasing steadily since 2020.